Pitavastatin and metformin synergistically activate apoptosis and autophagy in pancreatic cancer cells

Pancreatic cancer is the seventh leading cause of cancer‐related deaths globally. Metformin is the standard first‐line of treatment for hyperglycemia in Type 2 diabetes, whereas pitavastatin is a cholesterol‐lowering drug used to prevent cardiovascular diseases. Both these agents evidently exert …